New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025Upon FDA approval, ...
The US Food and Drug Administration (FDA) has approved Neffy, a nasal spray for treating severe allergic reactions in children aged 4 and above. This is the first emergency allergy treatment ...
Targeting final FDA approval of YUTREPIA after expiration of regulatory exclusivity on May 23, 2025Advancing pipeline of inhaled treprostinil products in clinical studiesStrengthened financial positio ...
Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 millionCash and cash ...
With companies constantly developing new therapies and technologies, the biotech industry is a hotbed of innovation. This dynamic environment ...
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...
WHTM Harrisburg on MSN9h
Food safety legislation would require warning labels for some dyes and chemicalsNew bipartisan legislation would increase awareness about what’s in food. Products that contain certain dyes and chemicals would be required to have warning ...
This press release aims to clarify what Arialief is, how it works, and why so many people are asking questions like "Is ...
Capricor presented preclinical data at the 2024 American Association of Extracellular Vesicles (AAEV) Annual Meeting. The ...
Stockhead on MSN4h
Lunch Wrap: ASX rebounds after Powell’s relaxed stance; Nanosonics gets FDA green lightThe ASX has bounced back after Wall Street's surge. Meanwhile Nanosonics has soared on FDA approval, and Bitcoin is back ...
Q4 2024 Management View CEO Eef Schimmelpennink highlighted 2024 as a transformative year, marked by significant milestones, including the completion of the Phase 3 CLARITY study, submission and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback